H. von der Hardt

3.6k total citations
98 papers, 2.8k citations indexed

About

H. von der Hardt is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, H. von der Hardt has authored 98 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 14 papers in Physiology. Recurrent topics in H. von der Hardt's work include Cystic Fibrosis Research Advances (40 papers), Neonatal Respiratory Health Research (26 papers) and Inhalation and Respiratory Drug Delivery (20 papers). H. von der Hardt is often cited by papers focused on Cystic Fibrosis Research Advances (40 papers), Neonatal Respiratory Health Research (26 papers) and Inhalation and Respiratory Drug Delivery (20 papers). H. von der Hardt collaborates with scholars based in Germany, United States and United Kingdom. H. von der Hardt's co-authors include Gratiana Steinkamp, Burkhard Tümmler, Dietmar Grothues, Manfred Ballmann, Christian F. Poets, Ute Römling, Gerd Döring, Wolfgang Bernhard, H. Weißbrodt and Monika Gappa and has published in prestigious journals such as The Lancet, American Journal of Clinical Nutrition and Journal of Applied Physiology.

In The Last Decade

H. von der Hardt

93 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. von der Hardt Germany 30 2.0k 606 353 337 320 98 2.8k
Margaret E. Hodson United Kingdom 27 1.8k 0.9× 623 1.0× 141 0.4× 282 0.8× 340 1.1× 78 2.8k
G. Bellon France 24 2.1k 1.0× 1.3k 2.2× 405 1.1× 266 0.8× 371 1.2× 96 3.3k
K. Brownlee United Kingdom 23 1.7k 0.8× 269 0.4× 163 0.5× 255 0.8× 334 1.0× 67 2.2k
Patrick Lebecque Belgium 31 1.9k 0.9× 448 0.7× 344 1.0× 261 0.8× 367 1.1× 99 3.0k
Preston W. Campbell United States 23 2.3k 1.1× 345 0.6× 128 0.4× 226 0.7× 447 1.4× 38 2.9k
C. Michael Bowman United States 19 1.5k 0.7× 232 0.4× 153 0.4× 201 0.6× 344 1.1× 39 1.9k
B.M. Assael Italy 32 1.5k 0.7× 703 1.2× 113 0.3× 224 0.7× 585 1.8× 153 3.2k
J M Littlewood United Kingdom 26 1.6k 0.8× 282 0.5× 113 0.3× 495 1.5× 400 1.3× 72 2.5k
James F. Chmiel United States 36 3.0k 1.5× 800 1.3× 234 0.7× 211 0.6× 556 1.7× 81 4.4k
Charles R. Esther United States 30 1.6k 0.8× 804 1.3× 118 0.3× 259 0.8× 699 2.2× 93 3.4k

Countries citing papers authored by H. von der Hardt

Since Specialization
Citations

This map shows the geographic impact of H. von der Hardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. von der Hardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. von der Hardt more than expected).

Fields of papers citing papers by H. von der Hardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. von der Hardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. von der Hardt. The network helps show where H. von der Hardt may publish in the future.

Co-authorship network of co-authors of H. von der Hardt

This figure shows the co-authorship network connecting the top 25 collaborators of H. von der Hardt. A scholar is included among the top collaborators of H. von der Hardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. von der Hardt. H. von der Hardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hardt, H. von der, et al.. (2008). Indikationen zur Transplantation der Lunge*. DMW - Deutsche Medizinische Wochenschrift. 114(49). 1927–1932.
2.
Baumann, Ulrich, Malcolm King, Ernst M. App, et al.. (2004). Long‐Term Azithromycin Therapy in Cystic Fibrosis Patients: A Study on Drug Levels and Sputum Properties. Canadian Respiratory Journal. 11(2). 151–155. 42 indexed citations
3.
Rau, Gunnar A., Heike Dombrowsky, Andreas Gebert, et al.. (2003). Phosphatidylcholine metabolism of rat trachea in relation to lung parenchyma and surfactant. Journal of Applied Physiology. 95(3). 1145–1152. 9 indexed citations
4.
Dorsch, Martina, Wolfgang Bernhard, Julia R. Dorin, et al.. (2002). Residual <i>cftr</i> Expression Varies with Age in <i>cftr<sup>tm1Hgu</sup></i> Cystic Fibrosis Mice: Impact on Morphology and Physiology. Pathobiology. 70(2). 89–97. 12 indexed citations
5.
Ballmann, Manfred & H. von der Hardt. (2002). Hypertonic saline and recombinant human DNase: a randomised cross-over pilot study in patients with cystic fibrosis. Journal of Cystic Fibrosis. 1(1). 35–37. 57 indexed citations
6.
Baumann, Ulrich, et al.. (2001). Buccal Adherence of Pseudomonas aeruginosa in Patients with Cystic Fibrosis under Long-Term Therapy with Azithromycin. Infection. 29(1). 7–11. 34 indexed citations
7.
Stuhrmann, Manfred, H. von der Hardt, & H Fabel. (1999). Mukoviszidose. Der Internist. 40(5). 476–485. 1 indexed citations
8.
Niggemann, B., W Leupold, Angela Schuster, et al.. (1998). Prospective, double‐blind, placebo‐controlled, multicentre study on the effect of high‐dose, intravenous immunoglobulin in children and adolescents with severe bronchial asthma. Clinical & Experimental Allergy. 28(2). 205–210. 33 indexed citations
9.
Raymondos, Konstantinos, et al.. (1996). A method for the isolation and preparation of surfactant from tracheobronchial aspirates in infants and children for quantitative and pulsating bubble analysis. European Journal of Clinical Investigation. 26(11). 983–988. 3 indexed citations
10.
Bánovčin, Peter, J. Seidenberg, & H. von der Hardt. (1995). Pressure sensor plethysmography: a method for assessment of respiratory motion in children. European Respiratory Journal. 8(1). 167–171. 12 indexed citations
11.
Brandt, T, Stefanie Breitenstein, H. von der Hardt, & B. Tümmler. (1995). DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.. Thorax. 50(8). 880–882. 59 indexed citations
12.
Fauler, Joachim, A. Thon, Dimitrios Tsikas, H. von der Hardt, & Jürgen C. Frölich. (1994). Enhanced Synthesis of Cysteinyl Leukotrienes in Juvenile Rheumatoid Arthritis. Arthritis & Rheumatism. 37(1). 93–97. 21 indexed citations
13.
Poets, Christian F., et al.. (1993). Reliability of a pulse oximeter in the detection of hyperoxemia. The Journal of Pediatrics. 122(1). 87–90. 30 indexed citations
14.
Steinkamp, Gratiana, et al.. (1993). Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis. American Journal of Clinical Nutrition. 57(5). 685–689. 44 indexed citations
15.
Seidenberg, Jürgen, et al.. (1992). Hypoxemia in Infants with Biliary Atresia. Journal of Pediatric Gastroenterology and Nutrition. 15(2). 171–177.
16.
Steinkamp, Gratiana, Burkhard Tümmler, Monika Gappa, et al.. (1989). Long‐term tobramycin aerosol therapy in cystic fibrosis. Pediatric Pulmonology. 6(2). 91–98. 120 indexed citations
17.
Hardt, H. von der, et al.. (1986). Diagnostic implications and treatment of massive spontaneous atelectasis in childhood. Pediatric Pulmonology. 2(1). 65–69. 1 indexed citations
18.
Schönfeld, W., et al.. (1986). Die Bedeutung der Leukotriene bei chronischen Atemwegserkrankungen im Kindesalter. Journal of Molecular Medicine. 64(6). 257–264. 2 indexed citations
19.
Hardt, H. von der. (1985). Luftverschmutzung und bronchopulmonale Erkrankungen im Kindesalter. Monatsschrift Kinderheilkunde. 133(1). 2–5. 3 indexed citations
20.
Hardt, H. von der, et al.. (1973). [The radiological findings due to infection by Yersinia pseudotuberculosis and Yersinia enterocolitica--observation of five cases].. PubMed. 119(1). 26–35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret E. Hodson Breakdown of academic impact, for papers by G. Bellon Breakdown of academic impact, for papers by K. Brownlee Breakdown of academic impact, for papers by Patrick Lebecque Breakdown of academic impact, for papers by Preston W. Campbell Breakdown of academic impact, for papers by C. Michael Bowman Breakdown of academic impact, for papers by B.M. Assael Breakdown of academic impact, for papers by J M Littlewood Breakdown of academic impact, for papers by James F. Chmiel Breakdown of academic impact, for papers by Charles R. Esther
Rankless by CCL
2026